• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[小鼠尿路上皮蛋白II启动子对人膀胱癌细胞系的作用]

[Effect of mouse uroplakin II promoter on human bladder cancer cell line].

作者信息

Zhu Hong-jian, Zhang Zhi-qing, Zeng Xiang-fu, Wei Shou-shun, Xu Chun-xiao, Huang Guo-jin, Guo Ying-lu

机构信息

Institute of Urology, Peking University, Beijing 100034, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2004 Jan;26(1):22-5.

PMID:15059347
Abstract

OBJECTIVE

To study the effect of gene expression of mouse uroplakin II (UPII) promoter on human bladder cell cancer cell line.

METHODS

The mRNA expression of different cell lines was quantified by RT-PCR. Green fluorescent protein (GFP) and luciferase (Luc) were used as reporter genes. The plasmids carrying UPII or GFP were constructed and transfected into human cell lines of bladder transitional cell cancer (BIU-87), kindey cancer (GRC-1), vascular endothelium (EC), lung cancer cell line (A549) and skin fibroblast cell line (Hs27). GFP activity of cells was detected by confocual microscopy and flow cytometry (FCM). Luciferase value was measured by luminometer (microplate) and luciferase to beta-galactosidase ratios (L/G values) were used for evaluating transfection efficiency.

RESULTS

RT-PCR showed high expression level of UPII mRNA in bladder cancer cell line BIU-87, whereas low level or no expression in nonbladder cancer cell lines. The activity of GFP in bladder cancer (BIU-87) cell was higher than that in the other cell lines (5 - 10/HP versus 0 - 2/HP), with 4.34% positive cells in BIU-87 detected by FCM, but no positive cell was found in the other cell lines. L/G values indicated that the luciferase expression in human bladder cancer cells transfected with mouse UPII promoter was 1.8 - 8.2-fold as high as that in the nonbladder cell lines.

CONCLUSION

Mouse UPII promoter gene can be expressed in a tissue-specific fashion in human urinary bladder cancer. It is capable of initiating transcription of reporter genes in human bladder cancer cell line.

摘要

目的

研究小鼠尿血小板溶素II(UPII)启动子基因表达对人膀胱癌细胞系的影响。

方法

采用逆转录聚合酶链反应(RT-PCR)定量检测不同细胞系的mRNA表达。以绿色荧光蛋白(GFP)和荧光素酶(Luc)作为报告基因。构建携带UPII或GFP的质粒,并转染至人膀胱移行细胞癌(BIU-87)、肾癌(GRC-1)、血管内皮细胞(EC)、肺癌细胞系(A549)和皮肤成纤维细胞系(Hs27)。通过共聚焦显微镜和流式细胞术(FCM)检测细胞的GFP活性。用光度计测量荧光素酶值,并采用荧光素酶与β-半乳糖苷酶比值(L/G值)评估转染效率。

结果

RT-PCR显示,UPII mRNA在膀胱癌细胞系BIU-87中高表达,而在非膀胱癌细胞系中低表达或无表达。膀胱癌(BIU-87)细胞中的GFP活性高于其他细胞系(5 - 10/HP对0 - 2/HP),FCM检测发现BIU-87中有4.34%的阳性细胞,而其他细胞系未发现阳性细胞。L/G值表明,用小鼠UPII启动子转染的人膀胱癌细胞中荧光素酶表达比非膀胱细胞系高1.

相似文献

1
[Effect of mouse uroplakin II promoter on human bladder cancer cell line].[小鼠尿路上皮蛋白II启动子对人膀胱癌细胞系的作用]
Zhonghua Zhong Liu Za Zhi. 2004 Jan;26(1):22-5.
2
Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector.基于前列腺干细胞抗原增强子和尿路上皮蛋白 II 启动子的膀胱癌靶向组织特异性载体。
Urol Oncol. 2010 Mar-Apr;28(2):164-9. doi: 10.1016/j.urolonc.2008.02.002. Epub 2008 Apr 28.
3
Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.人尿路上皮蛋白II启动子的克隆、分析及其在膀胱癌基因治疗中的应用
Cancer Gene Ther. 2004 Apr;11(4):263-72. doi: 10.1038/sj.cgt.7700672.
4
Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.利用转基因小鼠和RT4细胞对8.8 kb猪uroplakin II启动子进行克隆及分子剖析。
J Cell Biochem. 2006 Oct 1;99(2):462-77. doi: 10.1002/jcb.20931.
5
Targeting gene expression of the mouse uroplakin II promoter to human bladder cells.将小鼠尿血小板溶素II启动子的基因表达靶向至人膀胱细胞。
Urol Res. 2003 Mar;31(1):17-21. doi: 10.1007/s00240-002-0294-x. Epub 2003 Feb 18.
6
A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.一种基于环氧化酶-2(COX-2)启动子的复制选择性腺病毒载体,用于靶向表达COX-2的人膀胱癌细胞。
Clin Cancer Res. 2004 Jul 1;10(13):4342-8. doi: 10.1158/1078-0432.CCR-03-0267.
7
Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.人尿路上皮蛋白II启动子的鉴定及其在构建CG8840中的应用,CG8840是一种尿路上皮特异性腺病毒变体,与多西他赛联合使用可消除已形成的膀胱肿瘤。
Cancer Res. 2002 Jul 1;62(13):3743-50.
8
Expression of a recombinant vector of a mutant human telomerase reverse transcriptase gene in human bladder cancer cell line T24, and its clinical significance.突变型人端粒酶逆转录酶基因重组载体在人膀胱癌细胞系T24中的表达及其临床意义。
BJU Int. 2005 Oct;96(6):890-4. doi: 10.1111/j.1464-410X.2005.05732.x.
9
[In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].人端粒酶逆转录酶基因启动子调控的胞嘧啶脱氨酶-胸苷激酶融合自杀基因治疗系统对卵巢癌细胞的体外治疗
Zhonghua Fu Chan Ke Za Zhi. 2004 Jun;39(6):390-5.
10
[A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].人端粒酶催化亚基启动子驱动的Hsv-tk/GCV对人肺癌细胞A549的选择性杀伤作用研究
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Apr;24(2):148-52.